- Preview Available
- Scholarly Journal
754 TIGIT-PVR is a key immune checkpoint and therapeutic target in HPV-positive head and neck squamous cell carcinomas
Le, Xiuning; Dang, Minghao; Hegde, Venkatesh; Jiang, Bo; Slay, Ravaen
; et al.
Journal for Immunotherapy of Cancer; London Vol. 9, Iss. Suppl 2, (Nov 2021): A788-A788.
DOI:10.1136/jitc-2021-SITC2021.754
We're sorry, there is no preview available.
Try and log in through your library or institution to see if they have access.
